Login
Evidence Feed
About
Diagnostics
New
FAQ
Contact us
^
Login
Contact us
to learn more about
our Premium Content: News alerts, weekly reports and conference planners
DRUG:
Roferon A (recombinant interferon alfa-2a)
Contact us
to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Associations
News
Trials
Company:
Roche
Drug class:
IFNα stimulant
Related drugs:
‹
pegylated interferon α -2a (3)
nadofaragene firadenovec-vncg (1)
JZP898 (0)
NG-641 (0)
SAR441000 (0)
Autologous CD34+ enriched HSPCs expressing interferon-alpha 2 (0)
peginterferon-α-2b (0)
IGN002 (0)
TAK-573 (0)
pegylated interferon α -2a (3)
nadofaragene firadenovec-vncg (1)
JZP898 (0)
NG-641 (0)
SAR441000 (0)
Autologous CD34+ enriched HSPCs expressing interferon-alpha 2 (0)
peginterferon-α-2b (0)
IGN002 (0)
TAK-573 (0)
›
Associations
News
Trials
VERI cancer hierarchy
Reset Filters
^
^
×
Unlock More with VERI
Sign up to access premium content
Email *
Password *
Confirm Password *
I'm not a robot
Please register with your email ID.
×
Unlock More with VERI
Sign up to access premium content
Email *
Password *
Confirm Password *
I'm not a robot
Please register with your email ID.